Clinical Trials Browser

Phase 2 × Agammaglobulinemia × Hizentra × Clear all

NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Phase 2 Recruiting

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency